|
||
|
||
|
FDA warns against using sex enhancer
Actra-Rx supplement could lead to unsafe blood pressure drop
Diedtra Henderson WASHINGTON - Nov 03, 2004 - The Food and Drug Administration warned consumers Tuesday not to buy or use the supplements Actra-Rx or Yilishen because they contain an ingredient that could lower blood pressure to unsafe levels. The FDA also instructed employees to block imports of the supplements, calling them ``dangerous... and even life-threatening.'' The agency said the supplement bears the name Yilishen when it is imported from China and is sold as Actra-Rx within the United States. Laura Alvey, an FDA spokeswoman, declined to comment further, saying the matter is under investigation that may lead to criminal or civil enforcement. When the FDA on March 27, 1998, approved Viagra, the first pill to treat impotence, it warned consumers not to use the drug in combination with products containing nitrates to avoid worrisome lowering of blood pressure. Because people buy Actra-Rx without a doctor's prescription, however, consumers receive no such warning. Despite an all-natural label, Actra-Rx capsules contain prescription-strength levels of sildenafil, the active ingredient in Viagra, according to a letter published in the Journal of the American Medical Association. A spokesman for Los Angeles-based Body Basics declined to comment. The company's voice mail identifies it as the manufacturer of Actra-Rx. The company's Web site continues to advertise Actra-Rx as a ``natural sexual enhancer'' available in starter kits of 10 pills for $78.99. In June 2003, Pfizer filed a trademark infringement suit against Body Basics, which had been using the name Niagra to sell the supplement. The federal court barred the company from using that name, said a Pfizer spokesman. |
|
|